TAMMY MELISSA SOLOMON: Open Payments
NPI 1801379078 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 47 payments from 14 companies in 2025. Trend: 2023 $930 · 2024 $535 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $203 |
| Novo Nordisk Inc | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Ardelyx, Inc. | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $46 |
| Amgen Inc. | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: UBRELVY, VRAYLAR, CAPLYTA, IBSRELA, GVOKE HYPOPEN, OTEZLA, Rybelsus, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
